1202 related articles for article (PubMed ID: 25475955)
1. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
[TBL] [Abstract][Full Text] [Related]
2. Application of rapid in vitro co-culture system of macrophages and T-cell subsets to assess the immunogenicity of dogs vaccinated with live attenuated Leishmania donovani centrin deleted parasites (LdCen-/-).
Viana KF; Fiuza JA; Gannavaram S; Dey R; Selvapandiyan A; Bartholomeu DC; da Silveira-Lemos D; Bueno LL; Dutra WO; Fujiwara RT; Nakhasi HL; Giunchetti RC
Parasit Vectors; 2016 Apr; 9():250. PubMed ID: 27136900
[TBL] [Abstract][Full Text] [Related]
3. Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs.
Fiuza JA; Santiago Hda C; Selvapandiyan A; Gannavaram S; Ricci ND; Bueno LL; Bartholomeu DC; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
Vaccine; 2013 Apr; 31(14):1785-92. PubMed ID: 23398933
[TBL] [Abstract][Full Text] [Related]
4. Live Attenuated
Banerjee A; Bhattacharya P; Dagur PK; Karmakar S; Ismail N; Joshi AB; Akue AD; KuKuruga M; McCoy JP; Dey R; Nakhasi HL
J Immunol; 2018 Jan; 200(1):163-176. PubMed ID: 29187586
[TBL] [Abstract][Full Text] [Related]
5. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
6. Intradermal Immunization of Leishmania donovani Centrin Knock-Out Parasites in Combination with Salivary Protein LJM19 from Sand Fly Vector Induces a Durable Protective Immune Response in Hamsters.
Fiuza JA; Dey R; Davenport D; Abdeladhim M; Meneses C; Oliveira F; Kamhawi S; Valenzuela JG; Gannavaram S; Nakhasi HL
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004322. PubMed ID: 26752686
[TBL] [Abstract][Full Text] [Related]
7. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
[TBL] [Abstract][Full Text] [Related]
8. Diminished CD4+/CD25+ T cell and increased IFN-gamma levels occur in dogs vaccinated with Leishmune in an endemic area for visceral leishmaniasis.
de Lima VM; Ikeda FA; Rossi CN; Feitosa MM; Vasconcelos RO; Nunes CM; Goto H
Vet Immunol Immunopathol; 2010 Jun; 135(3-4):296-302. PubMed ID: 20132994
[TBL] [Abstract][Full Text] [Related]
9. Canine Leishmania vaccines: still a long way to go.
Gradoni L
Vet Parasitol; 2015 Feb; 208(1-2):94-100. PubMed ID: 25620293
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs.
Petitdidier E; Pagniez J; Papierok G; Vincendeau P; Lemesre JL; Bras-Gonçalves R
PLoS Negl Trop Dis; 2016 May; 10(5):e0004614. PubMed ID: 27223609
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis.
Shahbazi M; Zahedifard F; Taheri T; Taslimi Y; Jamshidi S; Shirian S; Mahdavi N; Hassankhani M; Daneshbod Y; Zarkesh-Esfahani SH; Papadopoulou B; Rafati S
PLoS One; 2015; 10(7):e0132794. PubMed ID: 26197085
[TBL] [Abstract][Full Text] [Related]
12. Essential Role of Neutrophils in the Protective Immune Response Induced by a Live Attenuated
Bhattacharya P; Dey R; Saxena A; Karmakar S; Ismail N; Gannavaram S; Dagur PK; Satoskar M; Satoskar S; De Paoli S; Takeda K; McCoy JP; Nakhasi HL
J Immunol; 2020 Dec; 205(12):3333-3347. PubMed ID: 33177159
[TBL] [Abstract][Full Text] [Related]
13. Deletion of MIF gene from live attenuated LdCen
Fiuza JA; Gannavaram S; Gaze ST; de Ornellas LG; Alves ÉA; Ismail N; Nakhasi HL; Correa-Oliveira R
Sci Rep; 2023 May; 13(1):7362. PubMed ID: 37147351
[TBL] [Abstract][Full Text] [Related]
14. Antibody responses induced by Leish-Tec®, an A2-based vaccine for visceral leishmaniasis, in a heterogeneous canine population.
Testasicca MC; dos Santos MS; Machado LM; Serufo AV; Doro D; Avelar D; Tibúrcio AM; Abrantes Cde F; Machado-Coelho GL; Grimaldi G; Gazzinelli RT; Fernandes AP
Vet Parasitol; 2014 Aug; 204(3-4):169-76. PubMed ID: 24863572
[TBL] [Abstract][Full Text] [Related]
15. Generation of growth arrested Leishmania amastigotes: a tool to develop live attenuated vaccine candidates against visceral leishmaniasis.
Selvapandiyan A; Dey R; Gannavaram S; Solanki S; Salotra P; Nakhasi HL
Vaccine; 2014 Jun; 32(31):3895-901. PubMed ID: 24837513
[TBL] [Abstract][Full Text] [Related]
16. Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis.
Daneshvar H; Molaei MM; Kamiabi H; Burchmore R; Hagan P; Stephen Phillips R
Parasite Immunol; 2010; 32(11-12):722-30. PubMed ID: 21039612
[TBL] [Abstract][Full Text] [Related]
17. Leishmania donovani serine protease encapsulated in liposome elicits protective immunity in experimental visceral leishmaniasis.
Das P; Paik D; Naskar K; Chakraborti T
Microbes Infect; 2018 Jan; 20(1):37-47. PubMed ID: 28970116
[TBL] [Abstract][Full Text] [Related]
18. The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine.
Saraiva EM; de Figueiredo Barbosa A; Santos FN; Borja-Cabrera GP; Nico D; Souza LO; de Oliveira Mendes-Aguiar C; de Souza EP; Fampa P; Parra LE; Menz I; Dias JG; de Oliveira SM; Palatnik-de-Sousa CB
Vaccine; 2006 Mar; 24(13):2423-31. PubMed ID: 16386824
[TBL] [Abstract][Full Text] [Related]
19. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
Choudhury R; Das P; De T; Chakraborti T
Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
[TBL] [Abstract][Full Text] [Related]
20. Impact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-Challenge.
Resende LA; Aguiar-Soares RD; Gama-Ker H; Roatt BM; Mendonça LZ; Alves ML; Silveira-Lemos Dd; Corrêa-Oliveira R; Martins-Filho OA; Araújo MS; Fujiwara RT; Gontijo NF; Reis AB; Giunchetti RC
PLoS One; 2016; 11(8):e0161169. PubMed ID: 27556586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
